Article
AML with RUNX1::RUNX1T1 Cooperating two Mutations Relapsed Quickly after Achieving CR.
Clinical laboratory - 1 Mar 2024
XinhongYang, Wu Yingwei, Yang Xiaofeng, Wu Xue, Chen Yingying, Zhang Rongjuan, Zhang Zhihua
Abstract excerpt
BACKGROUND: Acute myeloid leukemia (AML) with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 has a relatively favorable prognosis with a high complete remission rate and long disease-free survival. METHODS AND RESULTS: Here we describe a patient who had AML with t(8;21)(q22;q22.1); RUNX1::RUNX1T1. Cooperating mutations including KRAS and ASXL1, and with other abnormal karyotype del(17) and with a myelomonocytic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
